| Literature DB >> 21305060 |
Susanne Harner1, Elfriede Noessner, Korinna Nadas, Anke Leumann-Runge, Matthias Schiemann, Fabienne L Faber, Joachim Heinrich, Susanne Krauss-Etschmann.
Abstract
BACKGROUND: The fetal immune system is characterized by a Th2 bias but it is unclear how the Th2 predominance is established. Natural killer T (NKT) cells are a rare subset of T cells with immune regulatory functions and are already activated in utero. To test the hypothesis that NKT cells are part of the regulatory network that sets the fetal Th2 predominance, percentages of Vα24(+)Vβ11(+) NKT cells expressing Th1/Th2-related chemokine receptors (CKR) were assessed in cord blood. Furthermore, IL-4 and IFN-γ secreting NKT cells were quantified within the single CKR(+) subsets.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21305060 PMCID: PMC3031538 DOI: 10.1371/journal.pone.0015714
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Percentages of chemokine receptor expressing Vα24+Vβ11+ NKT cells.
| Cord blood | Peripheral blood | p-value | |
|
| 57.08 | 54.58 (37.36–61.97) | 0.48 |
|
| 51.38 (32.30–58.73) | 48.75 (28.57–63.69 | 0.97 |
|
| 83.3 (71.8–90.4) | 17.6 (7.3–37.6) |
|
|
| 47.28 (27.87–56.80) | 79.78 (73.53–91.42) |
|
|
| 44.96 (41.36–63.21) | 43.50 (9.23–55.00) | 0.48 |
|
| 90.50 (66.67–97.78) | 43.67 (31.35–57.63) |
|
|
| 54.05 (32.00–77.78) | 35.95 (11.02–55.05) |
|
|
| 10.68 (4.35–17.19) | 4.98 (0.48–12.06) |
|
|
| 83.09 (69.28–99.17) | 94.09 (81.12–96.94) | 0.13 |
|
| 86.27 (69.77–99.17) | 84.30 (56.90–100.00) | 0.60 |
|
| 40.00 (26.22–43.88) | 31.48 (23.66–38.87) |
|
|
| 54.29 (50.00–66.13) | 48.28 (34.47–54.55) |
|
|
| 92.86 (88.75–97.20) | 98.00 (94.83–100.00) |
|
Data are shown as medians with (min-max.).
Figure 1Percentages of IL-4 and IFN-γ secreting NKT cells within total, CD4+ and DN subsets.
Horizontal bars indicate medians of percentages of IFN-γ (upper panel) and IL-4 (lower panel) secreting NKT cells within total (left), DN (middle) and CD4+ (right) NKT cell subsets. Cord blood (CB) NKT cells and peripheral blood (PB) NKT cells from adults are compared.
Figure 2Representative dot-plots of IL-4 and IFN-γ secreting NKT cells within total, CD4+ and DN subsets.
NKT cells from adult peripheral blood (upper two panels) and cord blood NKT cells (lower two panels) are compared. NKT cells were first identified by double positive staining of Vα24 and Vβ11 TCR chains (left). IFN-γ and IL-4 secreting NKT cells are shown within total (left), DN (middle) and CD4+ (right) NKT cell subsets.
Percentages of IL-4 and IFN-γ secreting NKT cells within NKT subsets.
| Cord blood (n = 14) | Peripheral blood (n = 12) | p-value | |||
|
| DN | IFN | 1.00 | 0.31 (0.12–4.10) | 0.07 |
| IL-4 | 1.23 (0.00–5.83) | 0.28 (0.00–3.35) | 0.12 | ||
| CD4 | IFN | 0.40 (0.00–2.34) | 0.33 (0.10–1.61) | 0.43 | |
| IL-4 | 0.28 (0.00–1.73) | 0.16 (0.00–0.60) | 0.49 | ||
|
| DN | IFN | 1.04 (0.10–4.58) | 0.43 (0.00–1.03) | 0.19 |
| IL-4 | 0.95 (0.00–6.81) | 0.17 (0.00–1.53) |
| ||
| CD4 | IFN | 0.39 (0.00–1.54) | 0.46 (0.09–3.34) | 0.27 | |
| IL-4 | 0.22 (0.00–0.78) | 0.18 (0.00–0.73) | 0.70 | ||
|
| DN | IFN | 2.30 (0.31–6.47) | 0.52 (0.00–2.34) |
|
| IL-4 | 2.17 (0.37–12.56) | 0.21 (0.00–1.55) |
| ||
| CD4 | IFN | 0.60 (0.00–2.10) | 0.50 (0.00–1.65) | 0.20 | |
| IL-4 | 0.52 (0.00–11.07) | 0.29 (0.00–1.01) | 0.09 | ||
|
| DN | IFN | 0.65 (0.05–3.72) | 0.29 (0.23–1.21) | 0.66 |
| IL-4 | 0.89 (0.20–4.66) | 0.19 (0.00–1.75) |
| ||
| CD4 | IFN | 0.30 (0.00–1.13) | 0.32 (0.00–1.83) | 0.50 | |
| IL-4 | 0.25 (0.00–2.00) | 0.27 (0.00–0.77) | 0.86 | ||
|
| DN | IFN | 1.84 (0.10–8.59) | 0.91 (0.45–4.07) | 0.08 |
| IL-4 | 2.16 (0.43–14.12) | 0.52 (0.13–3.66) |
| ||
| CD4 | IFN | 0.28 (0.00–2.14) | 0.42 (0.17–2.47) | 0.15 | |
| IL-4 | 0.60 (0.00–2.83) | 0.45 (0.12–1.46) | 0.85 | ||
|
| DN | IFN | 0.34 (0.10–2.56) | 0.06 (0.00–0.65) |
|
| IL-4 | 0.43 (0.00–2.70) | 0.15 (0.00–1.45) |
| ||
| CD4 | IFN | 0.16 (0.00–3.00) | 0.16 (0.00–1.42) | 0.80 | |
| IL-4 | 0.28 (0.00–0.66) | 0.10 (0.00–0.72) | 0.19 | ||
|
| DN | IFN | 0.87 (0.14–2.80) | 0.43 (0.00–3.17) | 0.11 |
| IL-4 | 0.94 (0.40–5.29) | 0.27 (0.00–1.82) |
| ||
| CD4 | IFN | 0.16 (0.00–1.07) | 0.30 (0.00–1.18) | 0.14 | |
| IL-4 | 0.16 (0.00–2.07) | 0.03 (0.00–0.60) | 0.20 | ||
|
| DN | IFN | 1.74 (0.00–9.15) | 0.88 (0.37–5.25) | 0.25 |
| IL-4 | 1.82 (0.14–9.86) | 0.92 (0.19–6.27) | 0.14 | ||
| CD4 | IFN | 0.22 (0.00–1.02) | 0.39 (0.00–0.88) | 0.12 | |
| IL-4 | 0.17 (0.00–3.58) | 0.40 (0.00–1.65) | 0.19 | ||
|
| DN | IFN | 1.23 (0.08–6.54) | 0.45 (0.00–1.54) | 0.11 |
| IL-4 | 1.01 (0.00–6.13) | 0.63 (0.11–1.86) | 0.16 | ||
| CD4 | IFN | 0.32 (0.00–1.53) | 0.58 (0.06–2.11) | 0.06 | |
| IL-4 | 0.10 (0.00–3.64) | 0.50 (0.16–1.17) |
| ||
|
| DN | IFN | 2.33 (0.67–13.82) | 0.93 (0.00–6.46) |
|
| IL-4 | 3.29 (1.06–15.15) | 0.76 (0.00–7.73) |
| ||
| CD4 | IFN | 0.23 (0.00–2.52) | 0.26 (0.00–1.29) | 0.98 | |
| IL-4 | 0.18 (0.00–2.86) | 0.20 (0.00–1.65) | 0.64 |
Data are shown as medians with (min-max.).
Sequences of sorted fetal and non-fetal NKT cell populations.
| AV24 | N | AJ18 | ||
|
|
|
| ||
|
| ||||
| Donor 1 | DN |
|
| |
| CD4+ |
|
| ||
| CD8+ |
|
| ||
| Donor 2 | DN |
|
| |
| CD4+ | ||||
| CD8+ | ||||
| Donor 3 | DN |
|
| |
| CD4+ |
|
| ||
| CD8+ |
|
| ||
|
| ||||
| Sample 1 | CD4+ |
|
| |
| Sample 2 | CD4+ |
|
| |
| Sample 3 | CD4+ |
|
|